FAQ: Ask a question

We’ve provided an FAQ below which we anticipate will answer questions. You are most welcome to get in touch to ask additional questions.

Q: Who are TNOG?

The Nottingham Oncology Group is a team of experience consultants who collaborate to deliver the best possible, timely, comprehensive cancer care to private medical patients in Nottinghamshire and from across the East Midlands.


Q: Where will I be treated?

We are based in the custom-built Park Cancer Centre, based at The Park Hospital in Nottinghamshire. The Centre is easily accessible with dedicated parking for patients outside the building. We occasionally use other facilities.


Q: Medical Insurance

As we are registered and approved by all the major insurers we are happy to see all patients with Private Medical Insurance. All insurers will only allow care to go ahead after pre-authorisation – which we always seek on your behalf. Insurance companies also like to be kept informed by their customers as well as receiving medical reports/requests from medical teams.


Q: Can I pay myself?

Whilst some patients self pay for their entire treatment privately, many patients self pay for a second opinion on their illness, or for investigations to be done quicker. We welcome requests for a second opinion, and will source a quote if you are paying for your medical treatment such as chemotherapy.  Either way you will be asked to pre-authorise your care by paying a deposit of money up front to cover potential costs. We do not routinely charge you more than insurers cover you for your private care.


Q: Parking

The Park Cancer Centre is easily accessible, has dedicated parking right outside for our patients which is free-of-charge.


Q: Transport

The vast majority of our patients are able to drive themselves to and from appointment though you may chose to bring a friend or relative with you (who will be made most welcome). We recognise attending daily for radiotherapy can be more challenging and we can make arrangements to support travel for radiotherapy if you would like us to.


Latest News

  • October 3, 2015
    Early Docetaxel for prostate cancer improves survival

    Early treatment with Docetaxel chemotherapy imp...

    Read More
  • July 30, 2015
    Prostate Cancer Genetic Signatures

    A better understanding of the genetics of prost...

    Read More
  • May 13, 2015
    Where are the voices for radiotherapy?

    It is not well publicised – but the main ...

    Read More